Boundless Bio, Inc. Common Stock Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 1 | -$0.80 | -$0.80 | -$0.80 |
| Q2 2024 | 1 | -$0.75 | -$0.75 | -$0.75 |
| Q3 2024 | 2 | -$0.80 | -$0.72 | -$0.76 |
| Q1 2025 | 2 | -$0.82 | -$0.82 | -$0.82 |
| Q2 2025 | 1 | -$0.87 | -$0.87 | -$0.87 |
| Q3 2025 | 1 | -$0.93 | -$0.93 | -$0.93 |
| Q4 2025 | 1 | -$1.05 | -$1.05 | -$1.05 |
Boundless Bio, Inc. Common Stock Earnings Date And Information
Boundless Bio, Inc. Common Stock last posted its earnings results on Thursday, November 7th, 2024. The company reported $-0.74 earnings per share for the quarter, topping analysts' consensus estimates of $-0.76 by $0.02. The company had revenue of 0 for the quarter and had revenue of 0 for the year. Boundless Bio, Inc. Common Stock has generated $-2 earnings per share over the last year ($-2.22 diluted earnings per share) and currently has a price-to-earnings ratio of -1.09. Boundless Bio, Inc. Common Stock has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, February 6th, 2025 based on prior year's report dates.
Boundless Bio, Inc. Common Stock Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 09/30/2024 | Q3 2024 | -$0.74 | $0 | $0 | ||
| 06/28/2024 | Q2 2024 | -$0.77 | $0 | $0 | ||
| 03/29/2024 | Q1 2024 | -$0.69 | $0 | |||
| 12/30/2023 | Q4 2023 | -$0.55 | $0 | |||
| 09/29/2023 | Q3 2023 | -$0.59 | $0 | |||
| 06/29/2023 | Q2 2023 | -$0.56 | $0 | |||
| 03/29/2023 | Q1 2023 | -$0.53 | $0 | |||
| 12/30/2022 | Q4 2022 | -$0.53 | $0 | |||
| 09/28/2022 | Q3 2022 | -$0.59 | $0 | |||
| 11/07/2019 | Q3 2019 | -$1.07 | -$3.14 | -2.07 | $0 | |
| 08/06/2019 | Q2 2019 | -$2.14 | $0 | |||
| 05/07/2019 | Q1 2019 | -$1.12 | $0 | |||
| 03/01/2019 | Q4 2018 | -$2.93 | $0 | |||
| 11/06/2018 | Q3 2018 | -$2.12 | $0 | |||
| 08/06/2018 | Q2 2018 | -$0.78 | -$1.29 | -0.51 | $0 | |
| 05/10/2018 | Q1 2018 | -$0.58 | $0 | |||
| 03/09/2018 | Q4 2017 | -$2.05 | $0 | |||
| 11/14/2017 | Q3 2017 | -$0.89 | -$1.50 | -0.61 | $0 | |
| 08/10/2017 | Q2 2017 | -$0.79 | -$0.93 | -0.14 | $0 | |
| 05/11/2017 | Q1 2017 | -$0.92 | -$0.41 | 0.51 | $0 |
Boundless Bio, Inc. Common Stock Earnings: Frequently Asked Questions
-
When is Boundless Bio, Inc. Common Stock's earnings date?
Boundless Bio, Inc. Common Stock has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, February 6th, 2025 based off last year's report dates.
-
Did Boundless Bio, Inc. Common Stock beat their earnings estimates last quarter?
In the previous quarter, Boundless Bio, Inc. Common Stock (:BOLD) reported $-0.74 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.76 by $0.02.
-
How can I listen to Boundless Bio, Inc. Common Stock's earnings conference call?
The conference call for Boundless Bio, Inc. Common Stock's latest earnings report can be listened to online.
-
How can I read Boundless Bio, Inc. Common Stock's conference call transcript?
The conference call transcript for Boundless Bio, Inc. Common Stock's latest earnings report can be read online.
-
How much profit does Boundless Bio, Inc. Common Stock generate each year?
Boundless Bio, Inc. Common Stock (:BOLD) has a recorded net income of $0. Boundless Bio, Inc. Common Stock has generated $-2.22 earnings per share over the last four quarters.
-
What is Boundless Bio, Inc. Common Stock's price-to-earnings ratio?
Boundless Bio, Inc. Common Stock (:BOLD) has a price-to-earnings ratio of -1.09 and price/earnings-to-growth ratio is 0.19.
